Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
about
Role of isavuconazole in the treatment of invasive fungal infectionsEmergence of azole-resistant aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human healthIsavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendationsIsavuconazole: A New Broad-Spectrum Triazole Antifungal AgentTriazole Resistance in Aspergillus Species: An Emerging Problem.Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.A Novel Environmental Azole Resistance Mutation in Aspergillus fumigatus and a Possible Role of Sexual Reproduction in Its Emergence.First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.Passive surveillance for azole-resistant Aspergillus fumigatus, United States, 2011-2013Isavuconazole: A New Option for the Management of Invasive Fungal Infections.Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR₃₄/L98H mutations in the cyp51A gene in India.Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.An anti-Aspergillus protein from Escherichia coli DH5α: putative inhibitor of siderophore biosynthesis in Aspergillus fumigatus.Composite survival index to compare virulence changes in azole-resistant Aspergillus fumigatus clinical isolates.Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection modelPrevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in AsiaEvidence for genetic differentiation and variable recombination rates among Dutch populations of the opportunistic human pathogen Aspergillus fumigatus.Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China.Nationwide Surveillance of Azole Resistance in Aspergillus DiseasesMolecular epidemiology of Aspergillus fumigatus isolates harboring the TR34/L98H azole resistance mechanism.Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.Azole preexposure affects the Aspergillus fumigatus population in patients.Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis.In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosisIs azole resistance in Aspergillus fumigatus a problem in Spain?cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility.Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis.Bibliometric analysis of literature on antifungal triazole resistance: 1980 - 2015.Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections.Azole resistance in Aspergillus: global status in Europe and Asia.Second- versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysis.Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections.Assessment of selection and resistance risk for demethylation inhibitor fungicides in Aspergillus fumigatus in agriculture and medicine: a critical review.Profile of isavuconazole and its potential in the treatment of severe invasive fungal infectionsChronic pulmonary aspergillosis.Current status of antifungal resistance and its impact on clinical practice.Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.Multiple mechanisms contribute to the development of clinically significant azole resistance in Aspergillus fumigatus.
P2860
Q26740837-5538AD56-5D23-4090-88EB-AC3F915EBAA1Q26999421-A18CE52E-1FA0-42E7-8C83-DF5CD3D3B257Q28067726-2764807E-EEDA-4F79-9B62-47FA2A1A0D51Q28082019-34E96E59-48B3-4287-B20D-B8FBCF3393E2Q30235566-0E7325D0-7DC9-4D30-B2F8-0FF18D754281Q30239051-AA9FC806-7125-47BF-9155-E74E6981E0A2Q33843857-0141AB8A-EE3D-4640-86A2-040BEA9D9298Q34057414-FDB62278-2A5A-4FA1-A51E-009DD75107D2Q34259732-AAAF90E0-8F55-45E5-9C39-47BDEE6A80EEQ34474946-FA9A5224-965E-4CD7-8B9B-803D836D42C8Q34534761-B663152B-3129-4AE2-A511-BE9E7031B30BQ34621506-D77DB80F-D491-4185-996D-5AEEC12255EAQ34966446-1807AAA3-8FBD-45A6-B438-3E9D900018BEQ34977071-EA134AD8-8169-4499-8A05-AC7B264156C0Q35385554-164F1924-CBD0-4015-8EF6-CAD7C5146B71Q35585364-4D4EC363-7BA8-43E8-B0E4-FA4F76BE4BD7Q35673582-7A06BBAB-E04C-4CF9-AF26-3AF97CF02021Q35746043-E4791A02-15A4-482A-AB24-DD0DAAD89B35Q35860149-FA8A1A39-DFE5-4528-B945-EABA4D5003BBQ36171422-62219E78-5411-46EB-964F-B89A3FC65C5FQ36172416-5BA2323E-02BC-4004-AF38-2DDFF5717E0EQ36172445-1BAA39DE-74E2-4E5C-BA1E-0253E076D9A2Q36505281-34E58528-4C32-4C5D-A9AD-B1844249F84EQ36558484-1CE0A7F1-19A5-4283-980F-0989B19848F0Q36757621-1A4678E6-ECCF-4ADC-8ED2-8F4BDAC9DD1FQ37026702-52281874-C038-4D18-8998-9EFF6813E9D5Q37036556-AA6B1058-D5A3-40F4-8B28-AF7EC9B83161Q37125086-FC93205C-E80C-4830-9DD1-6B246C6178B9Q37538782-AD3D3160-502C-4079-9624-461C4BD667E5Q37696920-FF519B56-A54D-4094-815D-79E9D9693429Q38005226-92429E7B-3769-41FC-B362-89CA1CCA495AQ38066613-FE68F2C3-78DA-414F-9A6A-BD0FE58A94D4Q38086013-9A33C49F-9EFD-4876-ADAA-8B4F44332CA9Q38103889-D6C8814A-0F2D-48DA-9ED4-20AD2675B68FQ38152396-C5D59598-68EB-40A4-8B1C-836BFA5ECE9EQ38159688-278EC2C3-F610-4F02-A16D-AC8683D8736AQ38168300-15263038-98B7-4D63-9936-AAD87615DD24Q38205859-73EE1788-7836-44A9-82A8-16F7BDF72226Q38222570-2733884E-81FF-4BF5-8EFE-CE752B1654DBQ38365013-EEE9C50E-BA5F-4596-A0DD-3BBFD5A419A1
P2860
Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Isolation of multiple-triazole ...... s in the cyp51A gene in India.
@en
Isolation of multiple-triazole ...... s in the cyp51A gene in India.
@nl
type
label
Isolation of multiple-triazole ...... s in the cyp51A gene in India.
@en
Isolation of multiple-triazole ...... s in the cyp51A gene in India.
@nl
prefLabel
Isolation of multiple-triazole ...... s in the cyp51A gene in India.
@en
Isolation of multiple-triazole ...... s in the cyp51A gene in India.
@nl
P2093
P2860
P356
P1476
Isolation of multiple-triazole ...... s in the cyp51A gene in India.
@en
P2093
Corné H Klaassen
Harbans S Randhawa
Shailendra N Gaur
Shallu Kathuria
P2860
P304
P356
10.1093/JAC/DKR443
P407
P577
2011-10-25T00:00:00Z